Matthew Ros Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew Ros.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew Ros. Matthew Ros is Chief Operating Officer in Epizyme, Inc. ($EPZM) and See Remarks in Epizyme, Inc. ($EPZM) and Director in Unum Therapeutics Inc. ($UMRX).

Latest Insider Trading Transactions of Matthew Ros

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, COGT, EPZM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 05 2021	COGT	Cogent Biosciences ...	Ros Matthew	Director	Option Exercise	A	9.08	2,068	18,777	2,068
Mar 15 2021	UMRX	Cogent Biosciences ...	Ros Matthew	Director	Option Exercise	A	8.45	60,000	507,000	60,000
Feb 02 2021	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Option Exercise	A	11.02	134,178	1,478,642	134,178
Feb 02 2021	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	28,125	0	84,082	56 K to 84.1 K (+50.26 %)
Jan 27 2021	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	11.41	2,872	32,770	55,957	58.8 K to 56 K (-4.88 %)
Jan 06 2021	UMRX	Cogent Biosciences ...	Ros Matthew	Director	Option Exercise	A	7.62	1,641	12,503	1,641
Oct 02 2020	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	2.26	9,247	20,898	9,247
Jul 06 2020	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	0.47	35,280	16,582	35,280
Jun 30 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	16.15	2,728	44,057	57,507	60.2 K to 57.5 K (-4.53 %)
Jun 30 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	6,000	0	60,235	54.2 K to 60.2 K (+11.06 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Option Exercise	M	9.58	68,651	657,677	104,787
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Option Exercise	M	12.45	2,289	28,498	107,577
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Option Exercise	M	9.12	41,063	374,495	110,557
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	21.65	68,651	1,486,294	51,798	120.4 K to 51.8 K (-57.00 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Buy	M	9.58	68,651	657,677	120,449	51.8 K to 120.4 K (+132.54 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	22.00	2,289	50,358	51,798	54.1 K to 51.8 K (-4.23 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Buy	M	12.45	2,289	28,498	54,087	51.8 K to 54.1 K (+4.42 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	20.50	41,063	841,792	51,798	92.9 K to 51.8 K (-44.22 %)
Jun 22 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Buy	M	9.12	41,063	374,495	92,861	51.8 K to 92.9 K (+79.28 %)
Jun 11 2020	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	0.63	14,331	9,029	14,331
Apr 08 2020	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	0.35	49,887	17,436	49,887
Mar 26 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	15.28	1,243	18,993	51,798	53 K to 51.8 K (-2.34 %)
Mar 26 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	1,563	0	53,041	51.5 K to 53 K (+3.04 %)
Mar 26 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	15.28	1,243	18,993	51,798	53 K to 51.8 K (-2.34 %)
Mar 26 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	1,563	0	53,041	51.5 K to 53 K (+3.04 %)
Feb 05 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Option Exercise	A	21.39	56,213	1,202,396	56,213
Feb 05 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	11,688	0	51,478	39.8 K to 51.5 K (+29.37 %)
Jan 27 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Payment of Exercise	F	22.40	2,395	53,648	39,790	42.2 K to 39.8 K (-5.68 %)
Jan 27 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	24.64	1,847	45,510	42,185	44 K to 42.2 K (-4.19 %)
Jan 27 2020	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	5,000	0	44,032	39 K to 44 K (+12.81 %)
Oct 03 2019	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	1.41	12,509	17,638	12,509
Jul 29 2019	UMRX	Unum Therapeutics ...	Ros Matthew	Director	Option Exercise	A	2.05	28,661	58,755	28,661
Jun 14 2019	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Sell	S	12.10	1,185	14,339	39,032	40.2 K to 39 K (-2.95 %)
Jun 14 2019	EPZM	Epizyme, Inc.	Ros Matthew	See Remarks	Grant	A	0.00	4,000	0	40,217	36.2 K to 40.2 K (+11.04 %)
Jan 28 2019	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	A	9.12	151,620	1,382,774	151,620
Jan 28 2019	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Grant	A	0.00	32,894	0	36,217	3.3 K to 36.2 K (+989.89 %)
Jan 28 2019	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	A	9.12	151,620	1,382,774	151,620
Jan 28 2019	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Grant	A	0.00	32,894	0	36,217	3.3 K to 36.2 K (+989.89 %)
Feb 13 2018	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	A	16.00	106,344	1,701,504	106,344
Feb 06 2018	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	M	9.58	72,264	692,289	0
Feb 06 2018	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Sell	S	17.20	519	8,927	2,603	3.1 K to 2.6 K (-16.62 %)
Feb 06 2018	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Sell	S	16.63	71,745	1,192,768	3,122	74.9 K to 3.1 K (-95.83 %)
Feb 06 2018	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Buy	M	9.58	72,264	692,289	74,867	2.6 K to 74.9 K (+2,776.18 %)
Mar 02 2017	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Grant	A	6.21	1,708	10,613	1,708	0 to 1.7 K
Feb 09 2017	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	A	12.45	109,866	1,367,832	109,866
May 17 2016	EPZM	Epizyme, Inc.	Ros Matthew	Chief Operating Off ...	Option Exercise	A	9.58	173,438	1,661,536	173,438

Page: 1